Professor Emeritus Lloyd Sansom, AO, Chair of the Australian Pharmaceutical Benefits Advisory Committee (PBAC), looks at how comparative effectiveness research helps give Australians "access to drugs that work at a cost they as individuals and we as a country can afford."
